DD237165A5 - Verfahren zur herstellung von carbonylverbindungen und deren salzen - Google Patents
Verfahren zur herstellung von carbonylverbindungen und deren salzen Download PDFInfo
- Publication number
- DD237165A5 DD237165A5 DD85280566A DD28056685A DD237165A5 DD 237165 A5 DD237165 A5 DD 237165A5 DD 85280566 A DD85280566 A DD 85280566A DD 28056685 A DD28056685 A DD 28056685A DD 237165 A5 DD237165 A5 DD 237165A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- compounds
- acid
- group
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH438884 | 1984-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD237165A5 true DD237165A5 (de) | 1986-07-02 |
Family
ID=4275188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85280566A DD237165A5 (de) | 1984-09-14 | 1985-09-12 | Verfahren zur herstellung von carbonylverbindungen und deren salzen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4853393A (el) |
| EP (2) | EP0174653A3 (el) |
| JP (2) | JPS6172751A (el) |
| KR (1) | KR890000225B1 (el) |
| AU (1) | AU4744985A (el) |
| DD (1) | DD237165A5 (el) |
| DK (2) | DK416885A (el) |
| ES (4) | ES8802025A1 (el) |
| FI (2) | FI853477L (el) |
| GR (2) | GR852216B (el) |
| HU (1) | HU194871B (el) |
| IL (1) | IL76366A (el) |
| NO (1) | NO853609L (el) |
| NZ (1) | NZ213461A (el) |
| PT (2) | PT81117B (el) |
| ZA (1) | ZA857034B (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK159420C (da) * | 1983-03-09 | 1991-03-11 | Ciba Geigy Ag | N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater |
| FI853477L (fi) * | 1984-09-14 | 1986-03-15 | Ciba Geigy Ag | Foerfarande foer framstaellning av karbonylfoereningar. |
| JPS61227567A (ja) * | 1985-04-01 | 1986-10-09 | Eisai Co Ltd | １，４−ジヒドロピリジン誘導体 |
| DE3682857D1 (en) * | 1985-09-13 | 1992-01-23 | Green Cross Corp | Dihydropyridinderivate. |
| EP0222702A3 (de) * | 1985-11-06 | 1988-01-07 | Ciba-Geigy Ag | Basische Carbonylverbindungen |
| DE3601397A1 (de) * | 1986-01-18 | 1987-07-23 | Bayer Ag | Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| ES2059416T3 (es) * | 1987-03-27 | 1994-11-16 | Byk Gulden Lomberg Chem Fab | 1,4-dihidropiridina-enantiomeros. |
| WO1988007531A1 (en) * | 1987-03-27 | 1988-10-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New optically active compounds |
| DE3724909A1 (de) * | 1987-07-28 | 1989-02-09 | Bayer Ag | Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| US5258519A (en) * | 1990-11-13 | 1993-11-02 | Glaxo Inc. | Dihydropyridine vasodilators agents |
| US5767131A (en) * | 1993-04-05 | 1998-06-16 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| US6211198B1 (en) | 1993-04-05 | 2001-04-03 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| WO2000058305A1 (en) * | 1999-03-26 | 2000-10-05 | Astrazeneca Ab | Novel compounds |
| CN100450483C (zh) * | 2000-04-11 | 2009-01-14 | 三共株式会社 | 含有钙阻滞剂的稳定药物组合物 |
| GB0013060D0 (en) * | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
| GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| GB0117899D0 (en) * | 2001-07-23 | 2001-09-12 | Astrazeneca Ab | Chemical compounds |
| SE0102809D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | Novel compounds |
| TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
| TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284634A (en) * | 1975-07-02 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same |
| JPS5283672A (en) * | 1976-01-01 | 1977-07-12 | Yamanouchi Pharmaceut Co Ltd | Novel 2-amino-1,4-dihydropyridine derivatives |
| US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
| WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
| WO1984002702A1 (en) * | 1983-01-11 | 1984-07-19 | Takeda Chemical Industries Ltd | Dihydropyridine derivatives |
| WO1983004023A1 (en) * | 1982-05-10 | 1983-11-24 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives |
| JPS58201765A (ja) * | 1982-05-10 | 1983-11-24 | Takeda Chem Ind Ltd | ジヒドロピリジン誘導体，その製造法および用途 |
| EP0094159B1 (en) * | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
| IT1198377B (it) * | 1982-06-03 | 1988-12-21 | Pierrel Spa | Esteri basici ad attivita' calcioanatagonista,procedimenti per la loro preparazione e relative composizioni farmaceutiche |
| US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
| EP0111455A3 (de) * | 1982-12-10 | 1984-07-25 | Ciba-Geigy Ag | Ungesättigte Lactone |
| US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
| FI853477L (fi) * | 1984-09-14 | 1986-03-15 | Ciba Geigy Ag | Foerfarande foer framstaellning av karbonylfoereningar. |
-
1985
- 1985-09-11 FI FI853477A patent/FI853477L/fi not_active Application Discontinuation
- 1985-09-11 FI FI853478A patent/FI853478L/fi not_active Application Discontinuation
- 1985-09-11 IL IL76366A patent/IL76366A/xx unknown
- 1985-09-11 EP EP85111493A patent/EP0174653A3/de not_active Withdrawn
- 1985-09-11 EP EP85111494A patent/EP0174654A3/de not_active Withdrawn
- 1985-09-12 PT PT81117A patent/PT81117B/pt unknown
- 1985-09-12 GR GR852216A patent/GR852216B/el unknown
- 1985-09-12 GR GR852215A patent/GR852215B/el unknown
- 1985-09-12 DD DD85280566A patent/DD237165A5/de not_active IP Right Cessation
- 1985-09-12 PT PT81116A patent/PT81116B/pt unknown
- 1985-09-13 JP JP60201940A patent/JPS6172751A/ja active Pending
- 1985-09-13 DK DK416885A patent/DK416885A/da not_active Application Discontinuation
- 1985-09-13 HU HU853460A patent/HU194871B/hu not_active IP Right Cessation
- 1985-09-13 JP JP60201941A patent/JPS6172752A/ja active Pending
- 1985-09-13 ES ES546946A patent/ES8802025A1/es not_active Expired
- 1985-09-13 DK DK416985A patent/DK416985A/da not_active Application Discontinuation
- 1985-09-13 KR KR1019850006706A patent/KR890000225B1/ko not_active IP Right Cessation
- 1985-09-13 ES ES546945A patent/ES8701158A1/es not_active Expired
- 1985-09-13 NZ NZ213461A patent/NZ213461A/xx unknown
- 1985-09-13 ZA ZA857034A patent/ZA857034B/xx unknown
- 1985-09-13 AU AU47449/85A patent/AU4744985A/en not_active Abandoned
- 1985-09-13 NO NO853609A patent/NO853609L/no unknown
-
1986
- 1986-04-29 ES ES554487A patent/ES8706669A1/es not_active Expired
- 1986-04-29 ES ES554488A patent/ES8800926A1/es not_active Expired
-
1987
- 1987-12-30 US US07/139,407 patent/US4853393A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD237165A5 (de) | Verfahren zur herstellung von carbonylverbindungen und deren salzen | |
| EP0071819B2 (de) | Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung | |
| EP0002208B1 (de) | Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung | |
| DE2935451A1 (de) | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel | |
| EP0343193A1 (de) | 1,4-dihydropyridine-enantiomere | |
| DE2940833A1 (de) | 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
| EP0111453A1 (de) | Amid-Verbindungen | |
| EP0083315B1 (de) | Pyridyl-N-oxid-Verbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE3209274A1 (de) | Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| EP0111455A2 (de) | Ungesättigte Lactone | |
| DD228547A5 (de) | Verfahren zur herstellung von neuen amid-verbindungen | |
| DE3412947A1 (de) | Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| DE2804519A1 (de) | Oxadiazolopyrimidin-derivate | |
| CH678322A5 (el) | ||
| DE3531498A1 (de) | Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln | |
| EP0222702A2 (de) | Basische Carbonylverbindungen | |
| EP0214094A1 (de) | 1,4-Dihydropyridinverbindungen | |
| DD297813A5 (de) | Verfahren zur herstellung von dihydropyridinamiden | |
| EP0001108A1 (de) | Neue 1,4-Dihydropyridazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| DE3445356A1 (de) | Halogenierte thiophen-verbindungen | |
| DE2258403A1 (de) | Basisch substituierte chinazolon-(2)derivate, verfahren zu deren herstellung und sie enthaltende arzneimittel | |
| EP0229381B1 (de) | Methioninsubstituierte 1,4-Dihydropyridine, Verfahren zur Herstellung und ihre Verwendung | |
| DE2745496A1 (de) | Neue 1-n-substituierte 1.4-dihydropyridazine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| EP0160256B1 (de) | Annellierte Furanone, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DE2508934A1 (de) | Neue substituierte 5-amino-4- formyl-carbamoyl-pyrazole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |